While the role of mesotrypsin in lung cancer has not been as well-studied, a transcriptional profiling study identified PRSS3 as one of several genes predictive of future distant metastasis and poor survival when expressed in early stage NSCLC tumors22. This evidence concerns the gene PRSS3 and non-small cell lung carcinoma.